Mexico Drug Delivery Devices Market - Growth, Trends, and Forecasts 2017 - 2022 - Product Image

Mexico Drug Delivery Devices Market - Growth, Trends, and Forecasts 2017 - 2022

  • ID: 4387443
  • Report
  • Region: Mexico
  • 70 pages
  • Mordor Intelligence
1 of 3
Mexico’s drug delivery devices market is currently estimated to be worth USD 2.15 billion for the year 2014 and is expected to reach USD 5.957 billion by the end of 2020. The CAGR during this period of the forecast is 22.59%.

Currently, North America dominates the global market owing to the fact that there is greater awareness and increase per capita income. The Latin America region is expected to show good growth in the future, primarily due to the increased awareness among the population.

This escalation is developing the need to analyze, review and forecast the growth of the drug delivery devices market. Owing to the rapid evolution of the market in the use of injectable drug delivery technology, medical device companies that are able to launch new innovative equipment will be rewarded with huge benefits.

Mexico Drug Delivery Devices Market-Market Dynamics

The report details several factors driving and restraining the market. Some of these are listed below.

Drivers

Some of the factors driving the growth of the market are:

Increased prevalence of chronic diseases
Technological advances
Increase in individual therapy
Increased understanding about drug metabolism among the population
Requirement of controlled drug release
Restraints

Injuries and infections fear while usage, the high cost of development, and strict regulatory framework are the major challenges faced by the drug delivery market.

The report studies in detail the markets for different drug delivery devices, which include the injectable, transdermal, ocular, implantable, oral, nasal, topic and pulmonary drug delivery devices. Injectable drug delivery systems currently dominate the global market.

This Report Offers:

Market analysis for Mexico’s drug delivery devices market, with region-specific assessments and competition analysis on the global and regional scale.
Market definition along with the identification of key drivers and restraints.
Identification of factors instrumental in changing the market scenario, rising prospective opportunities, and identification of key companies that can influence this market on a global and regional scale.
Extensively researched competitive landscape section with profiles of major companies along with their market share for the next five years.
Identification and analysis of the macro and micro factors that affect the market on both global and regional scale.
A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.
A wide-ranging knowledge and insights about the major players in this industry and the key strategies adopted by them to sustain and grow in the studied market.
Insights on the major countries/regions where this industry is blooming and to also identify the regions that are still untapped.
The various applications of drug delivery devices have been discussed in detail, in addition to a comprehensive overview of the market.
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1. INTRODUCTION
1.1 Study deliverables
1.2 Market Definition
1.3 Sizing Units
1.4 Base Currency
1.5 Review and forecast period years
1.6 General Study Assumptions
2. RESEARCH METHODOLOGY
2.1 Introduction
2.2 Analysis Methodology
2.3 Econometric forecast models
2.4 Research Assumptions
3. EXECUTIVE SUMMARY
4. KEY INFERENCES
5. MARKET OVERVIEW AND INDUSTRY TRENDS
5.1 Current market scenario
5.2 Technology Overview
5.3 New developments in therapeutics
5.4 Investment analysis
5.5 Porter’s Five Force Analysis
5.5.1 Bargaining Power of suppliers
5.5.2 Bargaining power of buyers
5.5.3 Degree of competition
5.5.4 Threat of substitution
5.5.5 Threat of new entrants
6. DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES ANALYSIS (DROC)
6.1 Market Drivers
6.1.1 Rise in the number of Chronic Obstructive Pulmonary Disease patients (COPD), TB, Asthma and Pneumonia cases
6.1.2 Technological advancements in the device
6.1.3 Increased disposable income
6.2 Market Restraints
6.2.1 Cost and operational difficulty for the use of device
6.2.2 Increased sophistication in the usage of the device
6.3 Market Opportunities
6.3.1 Increase in the number of private clinics and hospitals
6.4 Key Challenges
6.4.1 Lack of public awareness
6.4.2 India Respiratory device Market Segmentation
6.4.2.1 Segmentation by diagnostic and Services
6.4.2.2 Spirometers
6.4.2.3 Sleep Test Devices
6.4.2.4 Peak Flow Meters
6.4.2.5 Pulse Oximeter
6.4.3 Capnographs
6.4.3.1 By therapeutic devices
6.4.3.2 CPAP Devices
6.4.3.3 BI-PAP Devices
6.4.3.4 Humidifiers
6.4.3.5 Nebulizers
6.4.3.6 Oxygen Concentrators
6.4.3.7 Ventilators
6.4.3.8 Inhalers
6.4.4 Resuscitators
6.4.4.1 Disposables
6.4.4.2 Masks
6.4.4.3 Cannulas
6.4.4.4 Tubes
6.4.4.5 Filters
7. Breathing Circuits
8. COMPETITIVE LANDSCAPE
8.1 Mergers & Acquisitions
8.2 New Product Launches
8.3 Agreements, Collaborations & Partnerships
9. KEY VENDORS
9.1 GE Healthcare
9.2 Resmed Inc.
9.3 Chart Industries Inc.
9.4 AstraZeneca PLC
9.5 Medtronic
10. Analyst outlook for Investment Opportunities
11. Future outlook of the market
12. APPENDIX
12.1 Abbreviations
12.2 Bibliography
12.3 Disclaimer
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll